… curative, and novel disease modifying therapies, such as CAR-T cells. Christian Hedrich from University of Liverpool opens … may increase the risk of graft failure and GVHD, while CAR-T cells might offer a cure without immunological …

… the field. A major such new development is the arrival of CAR-T cells, which may turn in a true revolution for the … is making efforts to deliver a roadmap to implement CAR-T programs that overcome potential limitations, secure …

… piece of artwork from patients recovered through CAR-T cell therapy. We then get to hear a panel discussion from … with CRS and ICANS in DLBCL patients undergoing CAR-T cell therapy. Key messages: standardise hospital …

… talk us through it. Watch the video The Daily Debate CAR-T Cell Therapy: New Hope for Patients? For our first day’s debate, we focus CAR-T cell therapy, newly approved in the USA and Europe, but …

… there are 787,102 patients, 904,713 transplants, 14,538 CAR-T treatments, 8,817 Immunosuppressive Treatments and 58 Gene …

… most highly cited articles? Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST … Moiseev et al   Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy®: real-world experience …

… collaborations across stakeholders in the field of CAR T-cell therapies. The selection committee was composed by … selection committee: The Role of Bridging Therapy before CAR-T Cell Therapy in Diffuse Large B-cell Lymphoma: An …

… Multicentric evaluation of CAR-T cell induced pseudoprogression prevalence (PrevCARTiPP) …

… of the EBMT meetings, including the Annual Meetings and CAR-T Meetings where I have presented and chaired sessions. I …

… TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome Oral … responses leading to ICANS (Neurotoxicity associated with CAR T cell therapy) and ultimately improve immunotherapies. …